It is not clear whether APC mutations are sufficient for early colorectal adenomas to grow or whether additional mutations at other loci are required. We previously have screened 210 early colorectal adenomas from familial adenomatous polyposis patients for mutations and allelic loss at APC. Here, we determined whether allelic loss at APC had any effect on the nearby alpha-catenin gene. However, loss on 5q in familial adenomatous polyposis adenomas rarely extended as far as alpha-catenin, and no differences in alpha-catenin protein expression were found in tumors that showed loss encompassing both APC and alpha-catenin. We then screened all 210 tumors for mutations at candidate loci other than APC (K-ras, beta-catenin, and allelic loss at 1...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Aim: To determine the frequency of tumour budding and somatic APC mutation in a series of colorectal...
The roles of the intrinsic mutation rate and genomic instability in tumorigenesis are currently cont...
Although APC mutations occur at a high frequency in colorectal cancers, few studies have performed a...
In vitro data show that the adenomatous polyposis coli (APC) protein associates with the mitotic spi...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in familial ...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
In order to investigate the role of nonsynonymous variants of the APC gene in inherited predispositi...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Colon cancer is a common disease that can be sporadic or familial. An inactivated adenomatous polypo...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Aim: To determine the frequency of tumour budding and somatic APC mutation in a series of colorectal...
The roles of the intrinsic mutation rate and genomic instability in tumorigenesis are currently cont...
Although APC mutations occur at a high frequency in colorectal cancers, few studies have performed a...
In vitro data show that the adenomatous polyposis coli (APC) protein associates with the mitotic spi...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in familial ...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
Multiple rare nonsynonymous variants in APC predispose to colorectal adenomas. The mechanisms throug...
In order to investigate the role of nonsynonymous variants of the APC gene in inherited predispositi...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Colon cancer is a common disease that can be sporadic or familial. An inactivated adenomatous polypo...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in...
Aim: To determine the frequency of tumour budding and somatic APC mutation in a series of colorectal...
The roles of the intrinsic mutation rate and genomic instability in tumorigenesis are currently cont...